Clorox Company (The) (NYSE:CLX)‘s stock had its “hold” rating reaffirmed by investment analysts at Jefferies Group LLC in a research note issued on Wednesday. They presently have a $137.00 target price on the stock, up from their prior target price of $136.00. Jefferies Group LLC’s price objective points to a potential upside of 1.75% from the company’s current price. Jefferies Group also issued estimates for Clorox Company (The)’s Q1 2018 earnings at $1.41 EPS, Q2 2018 earnings at $1.35 EPS, Q3 2018 earnings at $1.26 EPS, Q4 2018 earnings at $1.63 EPS, FY2019 earnings at $6.00 EPS and FY2020 earnings at $6.37 EPS.

Several other analysts have also weighed in on the company. Vetr lowered Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price target on the stock. in a report on Tuesday, April 18th. BMO Capital Markets restated a “buy” rating and set a $136.00 price target on shares of Clorox Company (The) in a report on Thursday, May 4th. BidaskClub lowered Clorox Company (The) from a “hold” rating to a “sell” rating in a report on Wednesday, July 5th. Deutsche Bank AG restated a “hold” rating and set a $137.00 price target (up previously from $126.00) on shares of Clorox Company (The) in a report on Saturday, July 22nd. Finally, Royal Bank Of Canada set a $115.00 price target on Clorox Company (The) and gave the company a “hold” rating in a report on Monday, April 24th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $129.05.

Clorox Company (NYSE CLX) traded down 0.13% on Wednesday, hitting $134.47. 113,284 shares of the company’s stock traded hands. The stock has a 50 day moving average price of $134.34 and a 200-day moving average price of $133.08. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76. The stock has a market cap of $17.32 billion, a P/E ratio of 26.56 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last posted its earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.04. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the company earned $1.30 EPS. Equities analysts predict that Clorox Company will post $5.68 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/08/09/clorox-company-the-clx-given-hold-rating-at-jefferies-group-llc.html.

Hedge funds have recently added to or reduced their stakes in the company. TNB Financial acquired a new stake in Clorox Company (The) during the first quarter worth $464,000. First PREMIER Bank raised its stake in Clorox Company (The) by 2.1% in the first quarter. First PREMIER Bank now owns 3,550 shares of the company’s stock worth $479,000 after buying an additional 74 shares during the last quarter. CrestPoint Capital Management LLC acquired a new stake in Clorox Company (The) during the first quarter worth $216,000. Spirit of America Management Corp NY acquired a new stake in Clorox Company (The) during the first quarter worth $243,000. Finally, Bank of Montreal Can raised its stake in Clorox Company (The) by 55.1% in the first quarter. Bank of Montreal Can now owns 369,031 shares of the company’s stock worth $49,755,000 after buying an additional 131,122 shares during the last quarter. Institutional investors and hedge funds own 70.29% of the company’s stock.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.